Q1 2026 Resmed Inc Earnings Call Transcript

Oct 30, 2025 / 08:30PM GMT
Release Date Price: $26.16

Key Points

Positve
  • ResMed Inc (RMD) reported a strong quarter with 9% revenue growth, or 8% on a constant currency basis.
  • The company achieved high single-digit growth in devices across the US, Canada, and Latin America, and double-digit growth in masks and other categories.
  • ResMed Inc (RMD) is focused on strategic expansion of its mask portfolio with new product innovations, including the launch of two new full-face fabric masks.
  • The company's residential care software business delivered mid-single-digit growth, with strong performance from the Medifox platform.
  • ResMed Inc (RMD) achieved a 280 basis point year-over-year gross margin expansion, driven by supply chain efficiencies and disciplined business investments.
Negative
  • The residential care software business faced challenges in the skilled nursing facilities segment, impacting overall growth.
  • ResMed Inc (RMD) recorded a restructuring-related charge of $16 million due to workforce planning adjustments.
  • The company's effective tax rate increased to 22.3% from 19.2% due to global minimum tax legislation.
  • There is ongoing uncertainty regarding the competitive bidding program by CMS, which could impact reimbursement rates.
  • The software as a service (SaaS) segment experienced mid-single-digit growth, which is below typical levels, due to weaker performance in senior living and long-term care software.
Operator

Hello, and welcome to the Q1 fiscal year 2026 ResMed earnings conference call. My name is Kevin. I'll be your operator for today's call. (Operator Instructions) Also, please note, this conference call is being recorded. (Operator Instructions)

Let me hand the call over to Salli Schwartz, ResMed's Chief Investor Relations Officer.

Salli Schwartz
Resmed Inc - Chief Investor Relations Officer

Thanks, Kevin. I want to welcome our listeners to ResMed's first-quarter fiscal year 2026 earnings call. We are live webcasting this call, and the replay will be available on the Investor Relations section of our corporate website later today. Our earnings press release and presentation are both available online now.

During today's call, we will discuss several non-GAAP measures that we believe provide useful information for investors. This information is not intended to be considered in isolation or as a substitute for GAAP financial information. We encourage you to review the supporting schedules in today's earnings press release to reconcile these non

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot